C

Canntab Therapeutics Ltd
CNSX:PILL

Watchlist Manager
Canntab Therapeutics Ltd
CNSX:PILL
Watchlist
Price: 0.005 CAD
Market Cap: 194.6k CAD

Canntab Therapeutics Ltd
Investor Relations

Canntab Therapeutics Ltd. is a biopharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2011-04-21. The firm is focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The firm operates in one reportable operating, being engaged in the medical marijuana business. All property and equipment, right-of-use assets and intangible assets are located in Canada. Its hard pill cannabinoid formulations provide doctors, patients and consumers with medical grade solutions. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet. The company holds cannabis standard processing and sales for medical purposes license, a cannabis research license, and an industrial hemp license from health Canada.

Show more
Loading
PILL
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Richard C. Goldstein
Interim CEO, Co-Founder, CFO & Director
No Bio Available
Mr. Barry M. Polisuk B.A., LL.B
Secretary & Independent Director
No Bio Available
Mr. Joshi Laxminarayan
Chief Scientific Officer
No Bio Available
Mr. Eric Malinski
Director of Marketing
No Bio Available

Contacts

Address
ONTARIO
TORONTO
1 Adelaide St E Suite 801
Contacts
+14168753609.0
canntab.ca